Zoster (Shingles) vaccine safety data

In the context of no safety signals identified during two years of surveillance in over 18,000 participants, AusVaxSafety concluded active surveillance of zoster vaccine safety in November 2018. It is important to re-emphasise that zoster vaccine should not be given to immunocompromised individuals. For more information please refer to the Therapeutic Goods Administration (TGA) website.

Influenza vaccine safety data 

Surveillance of 2019 influenza vaccine safety commenced from 1 April 2019. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here.

AusVaxSafety surveillance tool


Last updated September 2019